|
Sarcoma Care Adherence and Survival in Strasbourg
RECRUITINGSponsored by University Hospital, Strasbourg, France
Actively Recruiting
SponsorUniversity Hospital, Strasbourg, France
Started2025-11-27
Est. completion2027-01-27
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07864870
Summary
This retrospective monocentric study evaluates adherence to international clinical practice guidelines for soft tissue sarcoma management in Strasbourg and its impact on overall survival. It also compares practices and outcomes between two periods (2010-2016 and 2017-2024).
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Patient aged 18 years or older at first multidisciplinary tumor board presentation * Presented for multidisciplinary tumor board evaluation for soft tissue or visceral tumor * First presentation between 01/01/2017 and 31/12/2024 * Absence of opposition to reuse of medical data for research purposes Exclusion Criteria: * Presence of opposition to reuse of medical data for research purposes * Patient younger than 18 years at first presentation * Bone tumors, gastrointestinal stromal tumors (GIST), or Kaposi sarcoma * First presentation outside the study period * Management outside Alsace-Moselle * Duplicate records
Conditions2
CancerSoft Tissue Sarcoma (STS)
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorUniversity Hospital, Strasbourg, France
Started2025-11-27
Est. completion2027-01-27
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07864870